Invention Grant
- Patent Title: 5-methyl-4-fluoro-thiazol-2-yl compounds
-
Application No.: US17259993Application Date: 2019-07-24
-
Publication No.: US11999726B2Publication Date: 2024-06-04
- Inventor: Nicolas Jacques Francois Dreyfus , Peter James Lindsay-Scott
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Robert D. Shereda
- International Application: PCT/US2019/043219 2019.07.24
- International Announcement: WO2020/028115A 2020.02.06
- Date entered country: 2021-01-13
- Main IPC: C07D417/14
- IPC: C07D417/14
Abstract:
The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treating neurodegenerative diseases, such as Alzheimers disease.
Public/Granted literature
- US20210323958A1 5-METHYL-4-FLUORO-THIAZOL-2-YL COMPOUNDS Public/Granted day:2021-10-21
Information query
